Will The Stellar Run Of Diagnostic Stocks Continue?
A nurse is seen through a General Electric Co. positron emission tomography (PET) scanner in the diagnostic imaging area at the Hong Kong Integrated Oncology Centre in Hong Kong, China. (Photographer: Xaume Olleros/Bloomberg)

Will The Stellar Run Of Diagnostic Stocks Continue?

Shares of India’s two largest pathology chains by market value have returned the best gains so far this year in a bleeding pharma-healthcare market as investors bet on rising spends on diagnostics....
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.